COVID-19 and immunocompromised conditions: Ongoing challenging issue
One of the most serious complications of COVID-19 is the development of uncontrolled production of cytokines that poses a major factor contributing to COVID-19 morbidity and mortality. The exact effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on clinical and biochemi...
Main Authors: | Masoud Mardani, Atousa Hakamifard |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/20587392211016114 |
Similar Items
-
Hemophagocytic lymphohistiocytosis presented with fever of unknown origin: A case study and literature review
by: Atousa Hakamifard, et al.
Published: (2021-04-01) -
Hypertension and COVID-19: Ongoing Controversies
by: Marijana Tadic, et al.
Published: (2021-02-01) -
The ongoing battle against COVID-19
by: Qurratulain Hyder, et al.
Published: (2020-08-01) -
Pseudofungi in an Immunocompromised Patient with Breast Cancer and COVID-19
by: Nadeem Bilani, et al.
Published: (2020-01-01) -
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
by: Grégory Destras, et al.
Published: (2021-09-01)